[1]徐 杰.美沙拉嗪与柳氮磺吡啶治疗溃疡性结肠炎的效果比较[J].医学信息,2020,33(04):151-152,157.[doi:10.3969/j.issn.1006-1959.2020.04.049]
　XU Jie.Comparison of Mesalazine and Sulfasalazine in Treating Ulcerative Colitis[J].Medical Information,2020,33(04):151-152,157.[doi:10.3969/j.issn.1006-1959.2020.04.049]
点击复制

美沙拉嗪与柳氮磺吡啶治疗溃疡性结肠炎的效果比较()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年04期
页码:
151-152,157
栏目:
药物与临床
出版日期:
2020-02-15

文章信息/Info

Title:
Comparison of Mesalazine and Sulfasalazine in Treating Ulcerative Colitis
文章编号:
1006-1959（2020）04-0151-03
作者:
徐 杰
（沈阳市浑南区中心医院消化内科，辽宁 沈阳 110015）
Author(s):
XU Jie
(Department of Gastroenterology,Central Hospital of Hunnan District,Shenyang 110015,Liaoning,China)
关键词:
美沙拉嗪; 柳氮磺吡啶; 溃疡性结肠炎
Keywords:
Mesalazine; Sulfasalazine; Ulcerative colitis
分类号:
R547.62
DOI:
10.3969/j.issn.1006-1959.2020.04.049
文献标志码:
A
摘要:
目的 比较美沙拉嗪与柳氮磺吡啶治疗溃疡性结肠炎的临床效果。方法 选取2018年2月~2019年2月在我院诊治的70例溃疡性结肠炎患者为研究对象，采用随机数字表法分为对照组和观察组，各35例。对照组采用柳氮磺吡啶治疗，观察组采用美沙拉嗪治疗，比较两组临床治疗总有效率、临床症状（腹泻、腹痛、黏液便血）积分、结肠镜检评分、C反应蛋白水平及不良反应（恶心呕吐、粒细胞减少、头痛、外周血白细胞下降）发生情况。结果 观察组临床治疗总有效率为94.28%，高于对照组的82.85%，差异有统计学意义（P＜0.05）；治疗后两组腹泻、腹痛、黏液便血积分均低于治疗前，且观察组低于对照组，差异有统计学意义（P＜0.05）；治疗后两组结肠镜检评分均低于治疗前，且观察组低于对照组，差异有统计学意义（P＜0.05）；治疗后两组C反应蛋白水平均低是否于治疗前，且观察组低于对照组，差异有统计学意义（P＜0.05）；观察组不良反应发生率为8.57%，低于对照组的22.85%，差异有统计学意义（P＜0.05）。结论 美沙拉嗪治疗溃疡性结肠炎的临床效果优于柳氮磺吡啶，有助于炎症吸收，改善临床症状，且不良反应少，值得临床应用。
Abstract:
Objective To compare the clinical effects of mesalazine and sulfasalazine in the treatment of ulcerative colitis.Methods A total of 70 patients with ulcerative colitis diagnosed and treated in our hospital from February 2018 to February 2019 were selected as the research subjects. They were divided into the control group and the observation group by random number table method, 35 cases in each group. The control group was treated with sulfasalazine and the observation group was treated with mesalazine. The total effective rate, clinical symptoms (diarrhea, abdominal pain, mucus and blood in the stool) score, colonoscopy score, C-reactive protein level, and adverse reactions were compared between the two groups (Nausea and vomiting, granulocytopenia, headache, peripheral white blood cell decline).Results The total effective rate of clinical treatment in the observation group was 94.28%, which was higher than 82.85% in the control group,the difference was statistically significant (P<0.05).After treatment, the scores of diarrhea, abdominal pain, and mucus in the two groups were lower than before treatment, and the observation group was lower than the control group, the difference was statistically significant (P<0.05). The colonoscopy scores of the two groups were lower than before treatment and the observation group was lower than the control group, the difference was statistically significant (P<0.05);The C-reactive protein level in the two groups after treatment was lower than before the treatment, and the observation group was lower than the control group, the difference was statistically significant (P<0.05); the incidence of adverse reactions in the observation group was 8.57%, lower than 22.85% in the control group,the difference was statistically significant(P<0.05).Conclusion Mesalazine is superior to sulfasalazine in the treatment of ulcerative colitis, which is helpful for inflammation absorption, improves clinical symptoms, and has fewer adverse reactions, which is worthy of clinical application.

参考文献/References:

[1]黄志养,金捷,朱丽明,等.美沙拉嗪口服联合甲硝唑保留灌肠对溃疡性结肠炎患者的临床疗效[J].中国基层医药,2017,24(8):1178-1181. [2]中华医学会消化病学分会炎症性肠病学组.建立我国炎症性肠病诊治中心质量控制指标的共识[J].中华内科杂志,2016, 55(7):568-571. [3]张小河.美沙拉嗪联合益生菌与柳氮磺吡啶治疗溃疡性结肠炎的临床疗效比较[J].现代诊断与治疗,2014,25(6):1279-1280. [4]夏代菊.美沙拉嗪对溃疡性结肠炎患者临床症状和结肠镜下评分改善观察[J].浙江临床医学,2014,14(9):1088-1089. [5]李杨麟,喻晓东,苏林,等.美常安联合柳氮磺吡啶治疗溃疡性结肠炎的疗效及对血清TNF-α、IL-6、IL-8水平的影响[J].现代生物医学进展,2016,16(10):1926-1929. [6]张树惠.美沙拉嗪和柳氮磺吡啶对溃疡性结肠炎患者血清炎性因子表达的影响[J].国际医药卫生导报,2016,22(3):375-378. [7]王爽,郑秀艳,孙文华,等.美沙拉嗪对溃疡性结肠炎患者血清CRP,IL-10及TNF-α水平的影响[J].现代生物医学进展,2017,17(14):2693-2696. [8]丁海荣,王丙信,任清华,等.复方甘草酸苷联合柳氮磺吡啶治疗溃疡性结肠炎的临床研究[J].现代药物与临床,2016,31(3):367-370. [9]李杨麟,喻晓东,苏林,等.美常安联合柳氮磺吡啶治疗溃疡性结肠炎的疗效及对血清TNF-α、IL-6、IL-8水平的影响[J].现代生物医学进展,2016,16(10):1926-1929.

相似文献/References:

[1]靖 洁.美沙拉嗪联合双歧杆菌三联活菌治疗溃疡性结肠炎的疗效[J].医学信息,2021,34(13):163.[doi:10.3969/j.issn.1006-1959.2021.13.045]
　JING Jie.Efficacy of Mesalazine Combined with Live Bifidobacterium Triple Viable Bacteria in the Treatment of Ulcerative Colitis[J].Medical Information,2021,34(04):163.[doi:10.3969/j.issn.1006-1959.2021.13.045]
[2]钟 烨,余 勇.葛根芩连汤联合美沙拉嗪治疗溃疡性结肠炎的疗效及对患者炎性因子的影响[J].医学信息,2023,36(16):141.[doi:10.3969/j.issn.1006-1959.2023.16.028]
　ZHONG Ye,YU Yong.Efficacy of Gegen Qinlian Decoction Combined with Mesalazine in the Treatment of Ulcerative Colitis and its Effect on Inflammatory Factors[J].Medical Information,2023,36(04):141.[doi:10.3969/j.issn.1006-1959.2023.16.028]

更新日期/Last Update: 2020-02-15